文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

老年患者经导管主动脉瓣置换术：机遇与挑战

Transcatheter Aortic Valve Replacement in Elderly Patients: Opportunities and Challenges.

作者信息

Huang Bing, Yan Hui, Li Yunyao, Zhou Qiping, Abudoureyimu Ayipali, Cao Guiqiu, Jiang Hong

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.

出版信息

J Cardiovasc Dev Dis. 2023 Jun 29;10(7):279. doi: 10.3390/jcdd10070279.

DOI:10.3390/jcdd10070279
PMID:37504535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380827/
Abstract

Over the past two decades, the rapid evolution of transcatheter aortic valve replacement (TAVR) has revolutionized the management of severe aortic stenosis (AS) in the elderly. The prevalence of comorbidities in elderly AS patients presents a considerable challenge to the effectiveness and prognosis of patients after TAVR. In this article, we aim to summarize some of the clinical aspects of the current use of TAVR in elderly patients and attempt to highlight the challenges and issues that need further consideration.

摘要

在过去二十年中，经导管主动脉瓣置换术（TAVR）的迅速发展彻底改变了老年重度主动脉瓣狭窄（AS）的治疗方式。老年AS患者中合并症的流行对TAVR术后患者的疗效和预后构成了相当大的挑战。在本文中，我们旨在总结目前TAVR在老年患者中应用的一些临床情况，并试图强调需要进一步考虑的挑战和问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbdf/10380827/54a8851ea801/jcdd-10-00279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbdf/10380827/54a8851ea801/jcdd-10-00279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbdf/10380827/54a8851ea801/jcdd-10-00279-g001.jpg

相似文献

[1]
Transcatheter Aortic Valve Replacement in Elderly Patients: Opportunities and Challenges.

J Cardiovasc Dev Dis. 2023-6-29

[2]
Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.

J Am Coll Cardiol. 2013-5-30

[3]
Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.

Circulation. 2021-3-9

[4]
Transcatheter aortic valve replacement (TAVR): Recent updates.

Prog Cardiovasc Dis. 2021

[5]
Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.

Ann Med. 2019-5-21

[6]
Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management.

Cureus. 2019-12-20

[7]
Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.

Cureus. 2018-4-17

[8]
Current Key Issues in Transcatheter Aortic Valve Replacement Undergoing a Paradigm Shift.

Circ J. 2019-4-5

[9]
Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.

BMC Cardiovasc Disord. 2023-1-18

[10]
The Prognosis of Elderly Patients with Aortic Stenosis after Transcatheter Aortic Valve Replacement.

Intern Med. 2021-2-15

引用本文的文献

[1]
Renal impairment in transcatheter aortic valve implantation: incidence, predictors, and prognostic significance.

BMC Cardiovasc Disord. 2025-7-18

[2]
TAVR in older adults with cardiogenic shock: current practice and future direction.

J Geriatr Cardiol. 2025-5-28

本文引用的文献

[1]
Stroke prevention during and after transcatheter aortic valve implantation: From cerebral protection devices to antithrombotic management.

Front Cardiovasc Med. 2022-10-17

[2]
Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series.

J Cardiol Cases. 2022-5-25

[3]
Transcatheter aortic valve implantation outcomes in patients with low flow low gradient aortic stenosis.

Rev Port Cardiol. 2022-8

[4]
Clinical Outcomes of Revascularization with Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Replacement: A Comprehensive Meta-Analysis.

Curr Probl Cardiol. 2022-11

[5]
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial.

EuroIntervention. 2022-9-20

[6]
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.

Eur Heart J. 2022-8-1

[7]
Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis.

Clin Cardiol. 2022-4

[8]
Delayed Total Atrioventricular Block After Transcatheter Aortic Valve Replacement Assessed by Implantable Loop Recorders.

JACC Cardiovasc Interv. 2021-12-27

[9]
Ambulatory Electrocardiographic Monitoring Following Minimalist Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv. 2021-12-27

[10]
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.

JACC Cardiovasc Interv. 2021-9-27

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索